Chief, Division of Abdominal Transplant Surgery
Professor of Surgery
Professor in Pediatrics
Office:
223 Hanes House, Durham, NC 27710
Campus Mail:
DUMC Box 3512 Med Ctr, Durham, NC 27710
Education and Training
- M.D., Wright State University, 1994
In the News
- A stranger donates part of her liver, giving the gift of life to infantDecember 28, 2015
- Duke Physicians Separate Conjoined TwinsJune 27, 2015
Selected Grants
- Novartis - CFZ533A2201 Study for Kidney Transplant Patients
- A multicenter, double-blind, randomized, placebo-controlled trial to evaluate the efficacy and safety of apraglutide in adult subjects with short bowel syndrome and intestinal failure (SBS-IF)
- Health system outreach to eliminate disparities in living kidney transplants
- Health system outreach to eliminate disparities in living kidney transplants
- Novartis - CCFZ533A2202 - Liver Transplant Patients
- Sample Collection for Prospera Enhancement by Detecting dd-cfDNA Levels (PEDAL Study)
- Short Bowel Syndrome Registry
- A multicenter randomized, controlled trial to compare the efficacy of ex-vivo normothermic machine perfusion with static cold storage in human liver transplantation
- Transplant Genomics - TruGraf testing
- A Prospective, Open-Label, Long-Term Safety and Efficacy of Teduglutide
- Effects of storage method on intestinal allograft immune profile and viability
- A Phase 2a Randomized open label study to assess Bleselumab
- BMS-EnList
- A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF QPI-1002 FOR PREVENTION OF DELAYED GRAFT FUNCTION IN RECIPIENTS OF A DONATION AFTER BRAIN DEATH OLDER DONOR KIDNEY TRANSPLANT (ReGIFT)
- Pharmacodynamic Study Investigating Two Doses of Teduglutide in Pediatric Subjects Through 17
- Transplant Social Worker Support for Live Kidney Donation in African Americans
- Evaluation of Acute Rejection Rates in de novo Renal Transplant Recipients Following
Thymoglobulin Induction, CNI-free, Nulojix (belatacept) -based Immunosuppression - A randomized, parallel-group, double-blind, placebo-controlled, multi-center study of eculizumab for the prevention of delayed graft function after kidney transplantation in adult subjects at increased risk of delayed graft function